Side-by-side comparison of AI visibility scores, market position, and capabilities
SF pay-per-mile auto insurance pioneer acquired by Lemonade (NYSE: LMND) Jul 2022 for ~$500M; 49-state licenses and 500M+ trip dataset now powering Lemonade Car telematics competing with Root and Progressive Snapshot for UBI auto insurance.
Metromile was a San Francisco-based pay-per-mile auto insurance company — acquired by Lemonade, Inc. (NYSE: LMND) in July 2022 for approximately $500 million (about $200 million net of cash) — that pioneered telematics-based usage-based insurance (UBI) in the United States, providing low-mileage drivers with auto insurance priced at a low base rate plus a per-mile fee tracked by the Metromile Pulse device (an OBD-II port dongle that measured mileage and provided vehicle diagnostics). At the time of acquisition, Metromile held insurance licenses in 49 states and had accumulated over 500 million car trip records representing a significant telematics dataset for AI-driven auto insurance modeling. Founded in 2011, Metromile expanded from Oregon to eight US states before the Lemonade acquisition integrated its operations into Lemonade's AI-powered insurance platform under SVP Dan Preston (Metromile's former CEO).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.